Reforming 340B to Serve the Interests of Patients, Not Institutions

This Viewpoint discusses reforms to the 340B Drug Pricing Program to focus revenues from the program on lower-income and uninsured patients.

Saved in:
Bibliographic Details
Published in:JAMA health forum 2024-07, Vol.5 (7), p.e241356
Main Authors: DiGiorgio, Anthony M, Winegarden, Wayne
Format: Article
Language:English
Subjects:
COVID-19 - epidemiology
Health care
Health care access
Health care policy
Health Care Reform - legislation & jurisprudence
Humans
Reforms
Revenue
United States
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This Viewpoint discusses reforms to the 340B Drug Pricing Program to focus revenues from the program on lower-income and uninsured patients.
ISSN:2689-0186
2689-0186
DOI:10.1001/jamahealthforum.2024.1356